Sophie Robinson1, David W Kissane2, Joanne Brooker3, Susan Burney1. 1. Department of Psychiatry, School of Clinical Sciences at Monash Health, Monash University, Melbourne, Victoria, Australia; School of Psychological Sciences, Monash University, Melbourne, Victoria, Australia; Cabrini Monash Psycho-oncology, Cabrini Health, Melbourne, Victoria, Australia. 2. Department of Psychiatry, School of Clinical Sciences at Monash Health, Monash University, Melbourne, Victoria, Australia; School of Psychological Sciences, Monash University, Melbourne, Victoria, Australia; Cabrini Monash Psycho-oncology, Cabrini Health, Melbourne, Victoria, Australia. Electronic address: david.kissane@monash.edu. 3. Department of Psychiatry, School of Clinical Sciences at Monash Health, Monash University, Melbourne, Victoria, Australia; Cabrini Monash Psycho-oncology, Cabrini Health, Melbourne, Victoria, Australia.
Abstract
CONTEXT: Demoralization can be understood as a condition that results from existential conflict. It presents with symptoms of hopelessness and helplessness caused by a loss of purpose and meaning in life. It is a significant mental health concern given there can be an associated desire for hastened death. OBJECTIVES: The aim of this systematic review was to synthesize the recent empirical evidence on demoralization in patients with progressive disease or cancer, including prevalence rates; the relationships between demoralization and sociodemographic, disease- and treatment-related, and psychological factors; and the psychometric properties of demoralization measures. METHODS: A comprehensive literature search using key words and subject headings was performed following PRISMA guidelines with nine electronic bibliographic databases, resulting in 25 studies (33 articles) with a total of 4545 participants reviewed. Full articles underwent methodological quality assessment, and correlational information was synthesized according to the strength of evidence. RESULTS: The findings suggest that demoralization is prevalent in patients with progressive disease or cancer and clinically significant in 13%-18%. A range of factors were consistently associated with demoralization: poorly controlled physical symptoms, inadequately treated depression and anxiety, reduced social functioning, unemployment, and single status. The Demoralization Scale has demonstrated good psychometric properties across five studies. CONCLUSION: Overall, this systematic review was limited by the extent of variability in the characteristics of studies. Patients who are single, isolated or jobless, have poorly controlled physical symptoms, or have inadequately treated anxiety and depressive disorders are at increased risk for demoralization. Clinical recognition of demoralization can trigger more focused interventions.
CONTEXT: Demoralization can be understood as a condition that results from existential conflict. It presents with symptoms of hopelessness and helplessness caused by a loss of purpose and meaning in life. It is a significant mental health concern given there can be an associated desire for hastened death. OBJECTIVES: The aim of this systematic review was to synthesize the recent empirical evidence on demoralization in patients with progressive disease or cancer, including prevalence rates; the relationships between demoralization and sociodemographic, disease- and treatment-related, and psychological factors; and the psychometric properties of demoralization measures. METHODS: A comprehensive literature search using key words and subject headings was performed following PRISMA guidelines with nine electronic bibliographic databases, resulting in 25 studies (33 articles) with a total of 4545 participants reviewed. Full articles underwent methodological quality assessment, and correlational information was synthesized according to the strength of evidence. RESULTS: The findings suggest that demoralization is prevalent in patients with progressive disease or cancer and clinically significant in 13%-18%. A range of factors were consistently associated with demoralization: poorly controlled physical symptoms, inadequately treated depression and anxiety, reduced social functioning, unemployment, and single status. The Demoralization Scale has demonstrated good psychometric properties across five studies. CONCLUSION: Overall, this systematic review was limited by the extent of variability in the characteristics of studies. Patients who are single, isolated or jobless, have poorly controlled physical symptoms, or have inadequately treated anxiety and depressive disorders are at increased risk for demoralization. Clinical recognition of demoralization can trigger more focused interventions.
Authors: Daniel C McFarland; Kelly M Shaffer; Heather Polizzi; John Mascarenhas; Marina Kremyanskaya; Jimmie Holland; Ronald Hoffman Journal: Psychosomatics Date: 2018-01-31 Impact factor: 2.386
Authors: Denis Gerstorf; Christiane A Hoppmann; Corinna E Löckenhoff; Frank J Infurna; Jürgen Schupp; Gert G Wagner; Nilam Ram Journal: Psychol Aging Date: 2016-03
Authors: Kelly M Trevino; Paul K Maciejewski; Megan Johnson Shen; Holly G Prigerson; Supriya Mohile; Charles Kamen; Ronald M Epstein; Paul Duberstein Journal: Support Care Cancer Date: 2018-11-01 Impact factor: 3.603
Authors: Loredana Buonaccorso; Gianfranco Martucci; Guido Miccinesi; Alice Maruelli; Carla Ripamonti Journal: Support Care Cancer Date: 2018-09-11 Impact factor: 3.603
Authors: Stephen Ross; Gabrielle Agin-Liebes; Sharon Lo; Richard J Zeifman; Leila Ghazal; Julia Benville; Silvia Franco Corso; Christian Bjerre Real; Jeffrey Guss; Anthony Bossis; Sarah E Mennenga Journal: ACS Pharmacol Transl Sci Date: 2021-03-18